Medical imaging case studies
Learn how we use imaging to determine patient safety, treatment efficacy, and disease progression
Our end-to-end imaging solutions streamline acquisition, ensure consistency across sites.
We help sponsors minimise trial delays, enhance decision-making, and meet stringent regulatory requirements with robust, data backed evidence
High-volume medical imaging to support a MASH clinical trial
A pivotal phase 3 randomised, double-blind study to improve MASH and reduce progression to cirrhosis and/or hepatic decompensation, with high volumes of scans across two imaging modalities.
Phase 3 Multiple Myeloma study
A large-pharma sponsor was looking for a medical imaging partner to support a four-year, phase 3 Multiple Myeloma study. This trial included 600 patients and 200 sites and required expedited start-up and turnaround times.
Phase 3 unresectable biliary tract carcinoma study
A large pharmaceutical sponsor required an accelerated medical imaging data delivery for regulatory submission on a phase 3 advanced and/or unresectable biliary tract carcinoma study that spanned 277 sites with 1,115 patients.